Hologic Inc logo

Hologic Inc

2
3
NAS:HOLX (USA)   Ordinary Shares
$ 77.38 +0.03 (+0.04%) 09:45 AM EST
36.67
P/B:
3.90
Market Cap:
$ 18.16B
Enterprise V:
$ 18.84B
Volume:
29.60K
Avg Vol (2M):
1.88M
Also Trade In:
Volume:
29.60K
Avg Vol (2M):
1.88M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for HOLX ( Hologic Inc ) from 1990 to Mar 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hologic stock (HOLX) PE ratio as of Mar 28 2024 is 36.67. More Details

Hologic Inc (HOLX) PE Ratio (TTM) Chart

To

Hologic Inc (HOLX) PE Ratio (TTM) Historical Data

Total 1264
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Hologic PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-03-28 36.6 2024-01-25 35.1
2024-03-27 36.7 2024-01-24 35.1
2024-03-26 36.1 2024-01-23 35.4
2024-03-25 35.9 2024-01-22 35.1
2024-03-22 35.7 2024-01-19 34.8
2024-03-21 35.8 2024-01-18 34.9
2024-03-20 35.6 2024-01-17 34.6
2024-03-19 36.2 2024-01-16 34.5
2024-03-18 36.2 2024-01-15 34.5
2024-03-15 36.0 2024-01-12 34.5
2024-03-14 35.7 2024-01-11 34.3
2024-03-13 36.2 2024-01-10 34.0
2024-03-12 35.9 2024-01-09 34.2
2024-03-11 36.2 2024-01-08 33.8
2024-03-08 36.5 2024-01-05 34.6
2024-03-07 36.2 2024-01-04 34.5
2024-03-06 35.6 2024-01-03 34.3
2024-03-05 35.0 2024-01-02 34.3
2024-03-04 35.4 2024-01-01 33.9
2024-03-01 34.9 2023-12-29 33.9
2024-02-29 35.0 2023-12-28 33.8
2024-02-28 35.1 2023-12-27 38.8
2024-02-27 35.7 2023-12-26 38.9
2024-02-26 35.5 2023-12-22 38.8
2024-02-23 36.1 2023-12-21 38.8
2024-02-22 36.0 2023-12-20 38.4
2024-02-21 35.9 2023-12-19 38.9
2024-02-20 35.4 2023-12-18 38.8
2024-02-19 35.0 2023-12-15 38.8
2024-02-16 35.0 2023-12-14 38.9
2024-02-15 35.0 2023-12-13 38.8
2024-02-14 34.7 2023-12-12 38.3
2024-02-13 34.7 2023-12-11 37.5
2024-02-12 35.1 2023-12-08 37.4
2024-02-09 34.8 2023-12-07 37.8
2024-02-08 34.8 2023-12-06 37.8
2024-02-07 35.0 2023-12-05 37.9
2024-02-06 35.1 2023-12-04 38.6
2024-02-05 34.1 2023-12-01 38.9
2024-02-02 34.3 2023-11-30 39.0
2024-02-01 35.3 2023-11-29 38.6
2024-01-31 35.3 2023-11-28 38.2
2024-01-30 35.5 2023-11-27 39.1
2024-01-29 35.5 2023-11-24 39.2
2024-01-26 35.3 2023-11-22 39.4

Hologic Inc (HOLX) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Hologic Inc logo
Hologic Inc
NAICS : 334517 SIC : 3844
ISIN : US4364401012

Share Class Description:

HOLX: Ordinary Shares
Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.